Age- and sex-dependent development of adrenocortical hyperactivity in a transgenic mouse model of Alzheimer's disease

Neurobiology of Aging

Volumn 25, Issue 7, 2004, Pages 893-904

  Touma, Chadi ^a   Ambrée, Oliver ^a   Görtz, Nicole ^a   Keyvani, Kathy ^b   Lewejohann, Lars ^a   Palme, Rupert ^c   Paulus, Werner ^b   Schwarze Eicker, Katja ^b   Sachser, Norbert ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Adrenal tyrosine hydroxylase activity; Alzheimer's disease; Amyloid ; Explorative and anxiety related behavior; Fecal corticosterone metabolites; Health check; HPA axis; Plasma corticosterone; SAM system; Transgenic mouse model TgCRND8

Indexed keywords

CORTICOSTERONE; GLUCOCORTICOID;

ADRENAL CORTEX; ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; BIOLOGICAL MONITORING; BODY WEIGHT; CONCENTRATION (PARAMETERS); ENDOCRINOLOGY; EXPLORATORY BEHAVIOR; FECES ANALYSIS; FEMALE; HEALTH STATUS; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; METABOLITE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PARAMETER; PLAQUE FORMING CELL; PRIORITY JOURNAL; SAMPLE; TECHNIQUE; TRANSGENIC MOUSE; WILD TYPE;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANXIETY; BODY WEIGHT; CORTICOSTERONE; CRICETINAE; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FECES; FEMALE; HIPPOCAMPUS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MOTOR ACTIVITY; PITUITARY-ADRENAL SYSTEM; SENILE PLAQUES; SEX FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 3042606876     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2003.09.004     Document Type: Article

References (109)

1. Archer J. Tests for emotionality in rats and mice: a review. Anim. Behav. 21:1973;205-235
2. Arnold S.E., Hyman B.T., Flory J., Damasio A.R., van Hoessen G.W. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex. 1:1991;103-116
3. Axelrod J., Reisine T.D. Stress hormones: their interaction and regulation. Science. 224:1984;452-459
4. Beynen A.C. Communication between rats of experiment-induced stress and its impact on experimental results. Anim. Welfare. 1:1992;153-159
5. Breuner C.W., Orchinik M. Plasma binding proteins as mediators of corticosteroid action in vertebrates. J. Endocrinol. 175:2002;99-112
6. Callahan M.J., Lipinski W.J., Brian F., Durham R.A., Pack A., Walker L.C. Augmented senile plaque load in aged female β-amyloid precursor protein-transgenic mice. Am. J. Pathol. 158:2001;1173-1177
7. Chapman P.F., Falinska A.M., Knevett S.G., Ramsay M.F. Genes, models and Alzheimer's disease. Trends Genet. 17:2001;254-261
8. Chishti M.A., Yang D.-S., Janus C., Phinney A.L., Horne P., Pearson J., et al. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 276:2001;21562-21570
9. Cummings B.J., Pike C.J., Shankle R., Cotman C.W. β-Amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol. Aging. 17:1996;921-933
10. Davis D.E., Christian J.J. Relation of adrenal weight to social rank of mice. Proc. Soc. Exp. Biol. Med. 94:1957;728-731
11. Davis K.L., Davis B.M., Greenwald B.S., Mohs R.C., Mathe A.A., Johns C.A., et al. Cortisol and Alzheimer's disease, I: basal studies. Am. J. Psychiatry. 143:1986;300-305
12. D'Hooge R., Deyn P.P. Applications of the Morris Water Maze in the study of learning and memory. Brain Res. Rev. 36:2001;60-90
13. Ely D.L., Henry J.P. Neuroendocrine response pattern in dominant and subordinate mice. Horm. Behav. 10:1978;156-169
14. Finch C.E. Neurons, glia, and plasticity in normal brain aging. Neurobiol. Aging. 24:2003;S123-S127
15. Fox W.M. Reflex-ontogeny and behavioral development of the mouse. Anim. Behav. 13:1965;234-241
16. Fu W., Luo H., Parthasarathy S., Mattson M.P. Catecholamines potentiate amyloid β-peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis. Neurobiol. Dis. 5:1998;229-243
17. Fuchs E., Flügge G. Stress, glucocorticoids and structural plasticity of the hippocampus. Neurosci. Biobehav. Rev. 23:1998;295-300
18. Gärtner K., Büttner D., Döhler K., Friedel R., Lindena J., Trautschold I. Stress response of rats to handling and experimental procedures. Lab. Anim. 14:1980;267-274
19. Gibbs R.B., Aggarwal P. Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline. Horm. Behav. 34:1998;98-111
20. Green P.S., Simpkins J.W. Neuroprotective effects of estrogens: potential mechanisms of action. Int. J. Dev. Neurosci. 18:2000;347-358
21. Green P.S., Gridley K.E., Simpkins J.W. Estradiol protects against β-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci. Lett. 218:1996;165-168
22. Green P.S., Gordon K., Simpkins J.W. Phenolic A-ring requirement for the neuroprotective effects of steroids. J. Steroid. Biochem. Mol. Biol. 63:1997;229-235
23. Haass C., Steiner H. Alzheimer disease gamma-secretase: a complex story of GxGD-Type presenilin. Trends Cell Biol. 12:2002;556-562
24. Haemisch A., Gärtner K. Dissociation between adrenal tyrosinehydroxylase and phenylethanolamine-N-methyltransferase activities following repeated experience of defeats in individually housed male DBA/2J mice. Physiol. Behav. 59:1996;1117-1122
25. Haemisch A., Voss T., Gärtner K. Effects of environmental enrichment on aggressive behavior, dominance hierarchies, and endocrine states in male DBA/2J mice. Physiol. Behav. 56:1994;1041-1048
26. Handa R.J., Burgess L.H., Kerr J.E., Keefe J.A. Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Horm. Behav. 28:1994;464-476
27. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 297:2002;353-356
28. Hatzinger M., Z'Brun A., Hemmeter U., Seifritz E., Baumann F., Holsboer-Trachsler E., et al. Hypothalamic-pituitary-adrenal system function in patients with Alzheimer's disease. Neurobiol. Aging. 16:1995;205-209
29. Henderson V.W. Estrogen replacement therapy for the prevention and treatment of Alzheimer's disease. CNS Drugs. 8:1997;343-351
30. Hennessy M.B., Levine S. Effects of various habituation procedures on pituitary-adrenal responsiveness in the mouse. Physiol. Behav. 18:1977;799-802
31. Henry J.P. Biological basis of the stress response. Integr. Physiol. Behav. Sci. 27:1992;66-83
32. Heuser I.J., Gotthardt U., Schweiger U., Schmider J., Lammers C.-H., Dettling M., et al. Age-associated changes of pituitary-adrenocortical hormone regulation in humans: importance of gender. Neurobiol. Aging. 15:1994;227-231
33. Höschl C., Hajek T. Hippocampal damage mediated by corticosteroids-a neuropsychiatric research challenge. Eur. Arch. Psychiatry Clin. Neurosci. 251:2001;II/81-II/88
34. Hsiao Ashe K. Learning and memory in transgenic mice modeling Alzheimer's disease. Learning Memory. 8:2001;301-308
35. Hyman B.T., van Hoessen G.W., Damasio A.R., Barnes C.L. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science. 225:1984;1168-1170
36. Jacobson L., Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr. Rev. 12:1991;118-134
37. Jaffe A.B., Toran-Allerand C.D., Greengard P., Gandy S.E. Estrogen regulates metabolism of Alzheimer amyloid β precursor protein. J. Biol. Chem. 269:1994;13065-13068
38. Janus C., Westaway D. Transgenic mouse models of Alzheimer's disease. Physiol. Behav. 73:2001;873-886
39. Janus C., Pearson J., McLaurin J., Mathews P.M., Jiang Y., Schmidt S.D., et al. Aβ peptide immunization reduces behavioral impairment and plaques in a model of Alzheimer's disease. Nature. 408:2000;979-982
40. Jucker M., Walker L.C., Schwarb P., Hengemihle J., Kuo H., Snow A.D., et al. Age-related deposition of glia-associated fibrillar material in brains of C57BL/6 mice. Neuroscience. 60:1994;875-889
41. Katzman R., Aronso M., Fuld P., Kawas C., Brown T., Morgenstern H., et al. Development of dementing illness in an 80-year-old volunteer cohort. Ann. Neurol. 25:1989;317-324
42. Kelly P.H., Bondolfi L., Hunziker D., Schlecht H.-P., Carver K., Maguire E., et al. Progressive age-related impairment of cognitive behavior in APP23 transgenic mice. Neurobiol. Aging. 24:2003;365-378
43. 2+ conductances: relevance to brain aging. PNAS. 89:1992;8527-8531
44. Kim J.J., Diamond D.M. The stressed hippocampus, synaptic plasticity and lost memories. Nature Rev. Neurosci. 3:2002;453-462
45. SW transgenic mouse model for Alzheimer's disease. Behav. Brain Res. 103:1999;145-162
46. LaBuda C.J., Mellgren R.L., Hale R.L. Sex differences in the acquisition of a radial maze task in the CD-1 mouse. Physiol. Behav. 76:2002;213-217
47. Landfield P.W., Eldridge J.C. Evolving aspects of the glucocorticoid hypothesis of brain aging: hormonal modulation of neuronal calcium homeostasis. Neurobiol. Aging. 15:1994;579-588
48. Landfield P.W., Waymire J.C., Lynch G. Hippocampal aging and adrenocorticoids: quantitative correlations. Science. 202:1978;1098-1102
49. Lathe R. Hormones and the hippocampus. J. Endocrinol. 169:2001;205-231
50. Laviola G., Adriani W., Morley-Fletcher S., Terranova M.L. Peculiar response of adolescent mice to acute and chronic stress and to amphetamine: evidence of sex differences. Behav. Brain Res. 130:2002;117-125
51. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 92:1987;180-185
52. Maeda K., Tanimoto K., Terada T., Shintani T., Kakigi T. Elevated urinary free cortisol in patients with dementia. Neurobiol. Aging. 12:1991;161-163
53. Makino S., Hashimoto K., Gold P.W. Multiple feedback mechanisms activating corticotropin-releasing hormone system in the brain during stress. Pharmacol. Biochem. Behav. 73:2002;147-158
54. McEwen B.S. Stress and hippocampal plasticity. Ann. Rev. Neurosci. 22:1999;105-122
55. McEwen B.S., Alves S.E. Estrogen actions in the central nervous system. Endocr. Rev. 20:1999;279-307
56. Mooradian A.D. Antioxidant properties of steroids. J. Steroid Biochem. Mol. Biol. 45:1993;509-511
57. Morgan T.E., Xie Z., Goldsmith S., Yoshida T., Lanzrein A.-S., Stone D., et al. The mosaic of brain glial hyperactivity during normal aging and its attenuation by food restriction. Neuroscience. 89:1999;687-699
58. Morrison J.H., Hof P.R. Life and death of neurons in the aging brain. Science. 278:1997;412-419
59. Mouton P.R., Long J.M., Lei D.-L., Howard V., Jucker M., Calhoun M.E., Ingram D.K. Age and gender effects on microglia and astrocyte numbers in brains of mice. Brain Res. 956:2002;30-35
60. Nagatsu T., Levitt M., Udenfriend S. A rapid and simple radioassay for tyrosine hydroxylase activity. Anal. Biochem. 9:1964;122-126
61. Näsman B., Olsson T., Fagerlund M., Eriksson S., Viitanen M., Carlström K. Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease. Biol. Psychiatry. 39:1996;311-318
62. Nichols N.R., Zieba M., Bye N. Do glucocorticoids contribute to brain aging? Brain Res. Rev. 37:2001;273-286
63. O'Brien J.T., Ames D., Schweitzer I. HPA Axis Function in Depression and Dementia: A Review. Int. J. Geriatr. Psych. 8:1993;887-898
64. O'Brien J.T., Ames D., Schweitzer I., Mastwyk M., Colman P. Enhanced adrenal sensitivity to adrenocorticotrophic hormone (ACTH) is evidence of HPA Axis hyperactivity in Alzheimer's disease. Psychol. Med. 26:1996;7-14
65. Paganini-Hill A., Henderson V.W. Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 140:1994;256-261
66. Palme R., Möstl E. Measurement of cortisol metabolites in faeces of sheep as a parameter of cortisol concentration in blood. Int. J. Mamm. Biol. 62(Suppl II):1997;192-197
67. Pascualy M., Petrie E.C., Brodkin K., Peskind E.R., Wilkinson C.W., Raskind M.A. Hypothalamic pituitary adrenocortical and sympathetic nervous system responses to the cold pressor test in Alzheimer's disease. Biol. Psychiatry. 48:2000;247-254
68. Pedersen W.A., Culmsee C., Ziegler D., Herman J.P., Mattson M.P. Aberrant stress response associated with severe hypoglycemia in a transgenic mouse model of Alzheimer's disease. J. Mol. Neurosci. 13:1999;159-165
69. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Meth. 14:1985;149-167
70. Peskind E.R., Raskind M.A., Wingerson D., Pascualy M., Thal L.J., Dobie D.J., et al. Hypothalamic-pituitary-adrenocortical axis responses to physostigmine: effects of Alzheimer's disease and gender. Biol. Psychiatry. 40:1996;61-68
71. Peskind E.R., Wilkinson C.W., Petrie E.C., Schellenberg G.D., Raskind M.A. Increased cerebrospinal fluid cortisol in Alzheimer's disease is a function of APOE genotype. Neurology. 56:2001;1094-1098
72. Petanceska S.S., Nagy V., Frail D., Gandy S. Ovariectomy and 17β-estradiol modulate the levels of Alzheimer's amyloid β peptides in brain. Neurology. 54:2000;2212-2217
73. Polleri A., Gianelli M.V., Murialdo G. Dementia: a neuroendocrine perspective. J. Endocrinol. Invest. 25:2001;73-83
74. Porter N.M., Landfield P.W. Stress hormones and brain aging: adding injury to insult? Nat. Neurosci. 1:1998;3-4
75. Price D.L., Sisodia S.S., Borchelt D.R. Genetic neurodegenerative diseases: the human illness and transgenic models. Science. 282:1998;1079-1083
76. Prior H., Sachser N. Effects of enriched housing environment on the behaviour of young male and female mice in four exploratory tasks. J. Exp. Anim. Sci. 37:1995;57-68
77. Raber J. Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. Mol. Neurobiol. 18:1998;1-22
78. Raber J., Akana S.F., Bhatnagar S., Dallman M.F., Wong D., Mucke L. Hypothalamic-pituitary-adrenal dysfunction in apoe -/- mice: possible role in behavioral and metabolic alterations. J. Neurosci. 20:2000;2064-2071
79. Rehman H.U. Role of CRH in the pathogenesis of dementia of Alzheimer's type and other dementias. Curr Opin. Investig. Drugs. 3:2002;1637-1642
80. Rogers D.C., Peters J., Martin J.E., Ball S., Nicholson S.J., Witherden A.S., et al. SHIRPA, a protocol for behavioral assessment: validation for longitudinal study of neurological dysfunction in mice. Neurosci. Lett. 306:2001;89-92
81. Sachser N., Lick C. Social stress in Guinea pigs. Physiol. Behav. 46:1989;137-144
82. Sapolsky R.M., Krey L.C., McEwen B.S. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr. Rev. 7:1986;284-301
83. Savaskan E., Olivieri G., Meier F., Ravid R., Müller-Spahn F. Hippocampal estrogen β-receptor immunoreactivity is increased in Alzheimer's disease. Brain Res. 908:2001;113-119
84. Seabrook G.R., Rosahl T.W. Transgenic animals relevant to Alzheimer's disease. Neuropharmacology. 38:1999;1-17
85. Seeman M.V. Psychopathology in women and men: focus on female hormones. Am. J. Psychiatry. 154:1997;1641-1647
86. Selkoe D.J. Alzheimer's disease: gene, proteins, and therapy. Physiol. Rev. 81:2001;741-766
87. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science. 298:2002;789-791
88. Selmanoff M.K., Goldman B.D., Ginsburg B.E. Serum testosterone, agonistic behavior and dominance in inbred strains of mice. Horm. Behav. 8:1977;107-119
89. Shughrue P.J., Merchenthaler I. Estrogen is more than just a "sex hormone": novel sites for estrogen action in the hippocampus and cerebral cortex. Front. Neuroendocrinol. 21:2000;95-101
90. Siegel S, Castellan NJ. Nonparametric statistics for the behavioral sciences. 2nd ed. New York: McGraw-Hill; 1988.
91. Spackman D.H., Riley V. Corticosterone concentrations in the mouse. Science. 200:1978;87-87
92. Swaab D.F., Raadsheer F.C., Endert E., Hofman M.A., Kamphorst W., Ravid R. Increased cortisol levels in aging and Alzheimer's disease in postmortem cerebrospinal fluid. J. Neuroendocrinol. 6:1994;681-687
93. Swaab D.F., Chung W.C.J., Kruijver F.P.M., Hofman M.A., Hestiantoro A. Sex differences in the hypothalamus in the different stages of human life. Neurobiol. Aging. 24:2003;S1-S16
94. Sweet R.A., Hamilton R.L., Lopez O.L., Klunk W.E., Wisniewski S.R., Kaufer D.I., et al. Psychotic symptoms in alzheimer's disease are not associated with more severe neuropathologic features. Int. Psychogeriat. 12:2000;547-558
95. Tang M.-X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., et al. Effects of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432
96. Touma C., Sachser N., Möstl E., Palme R. Effects of sex and time of day on metabolism and excretion of corticosterone in urine and feces of mice. Gen. Comp. Endocrinol. 130:2003;267-278
97. Touma C, Palme R, Sachser N. Analyzing corticosterone metabolites in fecal samples of mice: a noninvasive technique to monitor stress hormones. Horm Behav in press.
98. Turner R.S. Alzheimer's disease in man and transgenic mice-females at higher risk. Am. J. Pathol. 158:2001;797-801
99. van Dam D., D'Hooge R., Staufenbiel M., van Ginneken C., van Meir F., de Deyn P.P. Age-dependent cognitive decline in the app23 model precedes amyloid deposition. Eur. J. Neurosci. 17:2003;388-396
100. von Holst D. The concept of stress and its relevance for animal behavior. Adv. Study Behav. 27:1998;1-131
101. Walker L.C., LeVine H. Proteopathy: the next therapeutic frontier? Curr. Opin. Invest. Drugs. 3:2002;782-787
102. Walsh R.N., Cummins R.A. The open-field test: a critical review. Psychol. Bull. 83:1976;482-504
103. Westerman M.A., Cooper-Blacketer D., Mariash A., Kotilinek L., Kawarabayashi T., Younkin L.H., et al. The relationship between aβ and memory in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 22:2002;1858-1867
104. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., DeLong M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 215:1982;1237-1239
105. Witte PU, Matthaei H. Mikrochemische Methoden für Neurobiologische Untersuchungen. Springer Verlag; 1980.
106. Wong P.C., Cai H., Borchelt D.R., Price D.L. Genetically engineered mouse models of neurodegenerative diseases. Nature Neurosci. 5:2002;633-639
107. Xu H., Gouras G.K., Greenfield J.P., Vincent B., Naslund J., Mazzarelli L., et al. Estrogen reduces neuronal generation of alzheimer β-amyloid peptides. Nature Med. 4:1998;447
108. Yen S.C.C., Laughlin G.A. Aging and the adrenal cortex. Exp. Gerontol. 33:1998;897-910
109. Zheng H., Xu H., Uljon S.N., Gross R., Hardy K., Gaynor J., et al. Modulation of Aβ peptides by estrogen in mouse models. J. Neurochem. 80:2002;191-196